A Case of Severe COVID-19 in a Patient with Acute Graft-versus-Host Disease after Haploidentical Transplantation.
Dan HanYuqian SunRong XieXiaojian ZhuZhaodong ZhongPublished in: Case reports in hematology (2021)
We report a case of coronavirus disease 2019 (COVID-19) after haploidentical transplantation with acute graft-versus-host disease (aGVHD). COVID-19 and aGVHD were improved under treatment with arbidol, remdesivir, methylprednisolone, and ruxolitinib. However, eventually, the patient died of septic shock and multiple organ failure. It was concluded that the disease condition of this COVID-19 patient after transplantation was serious, complex, and variable, with poor prognosis.
Keyphrases
- coronavirus disease
- poor prognosis
- sars cov
- case report
- respiratory syndrome coronavirus
- liver failure
- septic shock
- long non coding rna
- stem cell transplantation
- bone marrow
- drug induced
- peripheral blood
- respiratory failure
- cell therapy
- mesenchymal stem cells
- hepatitis b virus
- cord blood
- low dose
- combination therapy
- extracorporeal membrane oxygenation